title: Association of gestational diabetes with abnormal maternal vascular endothelial function.
abstract: OBJECTIVE
  To evaluate vascular endothelial function in isolated small arteries from women with gestational diabetes.
  
  
  METHODS
  Small subcutaneous arteries (mean luminal diameter approximately 250 microns) were dissected from biopsies obtained at caesarean section in 14 normotensive women with gestational diabetes and in 18 normotensive nondiabetic pregnant women. Vascular function was determined after mounting the arteries on a small vessel myograph.
  
  
  RESULTS
  Pre-constricted arteries from gestational diabetic pregnant women demonstrated poor relaxation to acetylcholine, an endothelium-dependent vasodilator (pEC50, mean [SE], 6.98 [0.10] vs normal pregnant, 7.28 [0.08], P < 0.03; % maximum relaxation, median [range], 88.2 [42.4-99.4] vs normal pregnant 94.2 [71.8-100.0], P < 0.01). In the presence of indomethacin relaxation to acetylcholine was similar in both groups suggesting a deficiency in dilator prostaglandin synthesis in the arteries from the diabetic women. The nitric oxide synthase inhibitor NG-monomethyl-L-arginine further reduced sensitivity of arteries to acetylcholine but to a similar degree in both normal pregnant and gestational diabetic women. Relaxation to sodium nitroprusside, an indicator of sensitivity of the vascular smooth muscle to nitric oxide, was similar in both groups.
  
  
  CONCLUSIONS
  Maternal vascular endothelial dysfunction may contribute to the increased incidence of cardiovascular disorders in women with gestational diabetes.
authors.affiliation: Division of Obstetrics and Gynaecology, United Medical School, St. Thomas' Hospital, London, UK.
authors.forename: G A
authors.initials: GA
authors.lastname: Knock
authors.forename: A L
authors.initials: AL
authors.lastname: McCarthy
authors.forename: C
authors.initials: C
authors.lastname: Lowy
authors.forename: L
authors.initials: L
authors.lastname: Poston
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D016640:Diabetes, Gestational / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D009119:Muscle Contraction / Q000502:physiology; D009126:Muscle Relaxation / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000503:physiopathology*; D014655:Vascular Resistance; D019323:omega-N-Methylarginine
chemical_list: D000109:Acetylcholine; D001120:Arginine; D004791:Enzyme Inhibitors; D007213:Indomethacin; C092506:N(G)-monomethylarginine acetate; D019323:omega-N-Methylarginine